All Relations between cannabis and Nicotine

Publication Sentence Publish Date Extraction Date Species
Kenneth Blum, Peter K Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, Rajendra D Badgaiyan, Eliot Gardner, Zsolt Demetrovics, Claudia Fahlke, Brett C Haberstick, Kristina Dushaj, Mark S Gol. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. Journal of reward deficiency syndrome. vol 1. issue 3. 2020-10-01. PMID:27398406. david nutt and associates eloquently proposed that dopamine (da) may be central to psycho stimulant dependence and some what important for alcohol, but not important for opiates, nicotine or even cannabis. 2020-10-01 2023-08-13 Not clear
Eva Ceskova, Petr Silha. Novel treatment options in depression and psychosis. Neuropsychiatric disease and treatment. vol 14. 2020-10-01. PMID:29559781. new treatment options not yet available include cannabidiol, glutamate modulators, and nicotine receptors agonists. 2020-10-01 2023-08-13 Not clear
Ylenia Duca, Antonio Aversa, Rosita Angela Condorelli, Aldo Eugenio Calogero, Sandro La Vigner. Substance Abuse and Male Hypogonadism. Journal of clinical medicine. vol 8. issue 5. 2020-10-01. PMID:31121993. other substances such as nicotine, cannabis, and amphetamines alter spermatogenesis inducing oxidative stress and subsequent apoptosis in testicular tissue. 2020-10-01 2023-08-13 Not clear
B William Downs, Kenneth Blum, David Baron, Abdalla Bowirrat, Lisa Lott, Raymond Brewer, Brent Boyett, David Siwicki, A Kenison Roy, Arwen Podesta, Sampada Badgaiyan, Raju Hajela, Lyle Fried, Rajendra D Badgaiya. Death by Opioids: Are there non-addictive scientific solutions? Journal of systems and integrative neuroscience. vol 5. 2020-10-01. PMID:31824737. the human brain has not been designed to carve out specific drugs like opioids, alcohol, nicotine, cocaine, benzodiazepines or cannabis and process addictions such as gambling as distinct endophenotypes. 2020-10-01 2023-08-13 human
K Blum, M Febo, R D Badgaiya. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial. Austin addiction sciences. vol 1. issue 2. 2020-09-30. PMID:27840857. the food and drug administration (fda) has approved some medication-assisted treatments (mats) for alcoholism, opiate and nicotine dependence, but nothing for psychostimulant and cannabis abuse. 2020-09-30 2023-08-13 Not clear
Sarah C Akerman, Mary F Brunette, Douglas L Noordsy, Alan I Gree. Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Current addiction reports. vol 1. issue 4. 2020-09-29. PMID:27226947. randomized, controlled trials provide some support for use of the atypical antipsychotic clozapine for co-occurring cannabis use disorder, naltrexone and disulfiram for alcohol use disorder, and also nicotine replacement therapy, sustained-release bupropion and varenicline for tobacco use disorder. 2020-09-29 2023-08-13 Not clear
Neal Doran, Mark G Myers, John Correa, David R Strong, Lyric Tully, Kim Pulver. Marijuana use among young adult non-daily cigarette smokers over time. Addictive behaviors. vol 95. 2020-09-28. PMID:30875533. recent data regarding growth in concurrent use of nicotine and marijuana have raised concern that reductions in legal restrictions on marijuana use may increase risk for tobacco-related harms. 2020-09-28 2023-08-13 human
Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. 2020-09-28 2023-08-13 human
Kyle J Rutledge, Dianne L Plat. Acute Psychosis in Withdrawal from Nicotine Vaping in a Young Man with Comorbid Diabetic Ketoacidosis and Cannabis Use. Case reports in psychiatry. vol 2020. 2020-09-28. PMID:32566348. the current report presents the case of a young man with multiple medical comorbidities, including insulin-dependent diabetes mellitus on an insulin pump and presumed gilbert's disease, and chronic cannabis use who experienced acute agitation with hallucinations in the context of quitting his vape pen "cold turkey" or abruptly discontinuing use without a nicotine replacement. 2020-09-28 2023-08-13 Not clear
David G Gilbert, Norka E Rabinovich, Justin T McDanie. Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial. Psychopharmacology. vol 237. issue 5. 2020-09-15. PMID:32034447. given that tetrahydrocannabinol (thc) and nicotine have similar effects on negative affect (na), we hypothesized that a 7-mg nicotine patch (np) would reduce na-related cannabis (can) withdrawal symptoms in cannabis-dependent (cd) individuals who were not nicotine dependent. 2020-09-15 2023-08-13 Not clear
Raghunath Singh, Yashika Bansal, Ishwar Parhar, Anurag Kuhad, Tomoko Sog. Neuropsychiatric implications of transient receptor potential vanilloid (TRPV) channels in the reward system. Neurochemistry international. vol 131. 2020-09-03. PMID:31494132. recent evidence has highlighted trpv channels as potential targets for understanding modulation of the reward system and various forms of addiction (opioids, cocaine, amphetamines, alcohol, nicotine, cannabis). 2020-09-03 2023-08-13 Not clear
Luisa Ponzoni, Milena Moretti, Daniela Braida, Michele Zoli, Francesco Clementi, Paola Viani, Mariaelvina Sala, Cecilia Gott. Increased sensitivity to Δ European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 4. 2020-06-17. PMID:30773388. in order to study whether the nicotine delivered via e-cig acts as "a gateway drug" to the use of cannabis, we analysed the behavioural and molecular effects of 7 weeks' pre-exposure to air (air), e-cigs or cigs on addiction-related conditioned place preference (cpp) in mice using a sub-threshold (0.01 mg/kg) dose of delta-9-tetrahydrocannabinol (Δ 2020-06-17 2023-08-13 mouse
Mariel S Bello, Rubin Khoddam, Matthew D Stone, Junhan Cho, Yoewon Yoon, Jungeun Olivia Lee, Adam M Leventha. Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs. Behaviour research and therapy. vol 115. 2020-04-14. PMID:30558744. poly-product drug use disparities in adolescents of lower socioeconomic status: emerging trends in nicotine products, marijuana products, and prescription drugs. 2020-04-14 2023-08-13 Not clear
Brian J Fairman, C Debra Furr-Holden, Renee M Johnso. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prevention science : the official journal of the Society for Prevention Research. vol 20. issue 2. 2020-03-18. PMID:29770947. then, we examined whether using marijuana first predicted heavy marijuana use, cannabis use disorder (cud), alcohol use disorder (aud), nicotine dependence (nd), or lifetime use of other illegal drugs. 2020-03-18 2023-08-13 Not clear
Sara de la Salle, Lawrence Inyang, Danielle Impey, Dylan Smith, Joelle Choueiry, Renee Nelson, Jasmit Heera, Ashley Baddeley, Vadim Ilivitsky, Verner Knot. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans. Pharmacology, biochemistry, and behavior. vol 184. 2020-02-26. PMID:31283908. the high prevalence of concomitant cannabis and nicotine use has implications for sensory and cognitive processing. 2020-02-26 2023-08-13 Not clear
Natalia Estévez-Lamorte, Simon Foster, Dominique Eich-Höchli, Franz Moggi, Gerhard Gmel, Meichun Mohler-Ku. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. European archives of psychiatry and clinical neuroscience. vol 269. issue 6. 2020-02-04. PMID:30483874. we examined: (1) the contribution of adhd, as assessed at baseline, on the risky use of alcohol, nicotine and cannabis, and their corresponding use disorders (aud, nud, cud) at follow-up; and (2) the association between adhd and the course of outcomes (i.e., absence, initiation, maturing out, persistence) over 15 months. 2020-02-04 2023-08-13 Not clear
Natalia Estévez-Lamorte, Simon Foster, Dominique Eich-Höchli, Franz Moggi, Gerhard Gmel, Meichun Mohler-Ku. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. European archives of psychiatry and clinical neuroscience. vol 269. issue 6. 2020-02-04. PMID:30483874. men with adhd were more likely to exhibit persistent risky alcohol and nicotine use, and to mature out of risky cannabis use. 2020-02-04 2023-08-13 Not clear
Rocio Saravia, Marc Ten-Blanco, María T Grande, Rafael Maldonado, Fernando Berrender. Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice. Brain, behavior, and immunity. vol 75. 2020-01-23. PMID:30391635. treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of il1β and ifnγ in the hippocampus and the prefrontal cortex, respectively, and normalized ki67 levels. 2020-01-23 2023-08-13 mouse
Karin J H Verweij, Jorien L Treur, Jacqueline M Vin. Investigating causal associations between use of nicotine, alcohol, caffeine and cannabis: a two-sample bidirectional Mendelian randomization study. Addiction (Abingdon, England). vol 113. issue 7. 2019-12-09. PMID:29334416. in this exploratory study, we used mendelian randomization (mr) to examine the causality of well-established associations between nicotine, alcohol, caffeine and cannabis use. 2019-12-09 2023-08-13 Not clear
Anna N Pushkin, Angeline J Eugene, Valeria Lallai, Alan Torres-Mendoza, J P Fowler, Edison Chen, Christie D Fowle. Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood. PloS one. vol 14. issue 1. 2019-10-24. PMID:30703155. nicotine and cannabis use during adolescence has the potential to induce long lasting changes on affective and cognitive function. 2019-10-24 2023-08-13 mouse